ArrowMark Colorado Holdings LLC 13D and 13G filings for Heron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 5:42 pm Sale |
2022-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
ArrowMark Colorado Holdings LLC | 3,560,848 3.000% |
-2,845,017 (-44.41%) |
Filing |
| 2022-02-14 2:15 pm Purchase |
2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
ArrowMark Colorado Holdings LLC | 6,405,865 6.280% |
1,044,254 (+19.48%) |
Filing |
| 2021-02-16 1:29 pm Purchase |
2020-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
ArrowMark Colorado Holdings LLC | 5,361,611 5.900% |
5,361,611 (New Position) |
Filing |